DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/aedc8e/lyme_disease_pip) has announced the addition of Global Markets Direct's new report "Lyme Disease - Pipeline Review, H2 2011" to their offering.
Global Markets Direct's, 'Lyme Disease - Pipeline Review, H2 2011', provides an overview of the Lyme Disease therapeutic pipeline. This report provides information on the therapeutic development for Lyme Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lyme Disease. 'Lyme Disease - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Key Topics Covered:
- Introduction
- Global Markets Direct Report Coverage
- Lyme Disease Overview
- Therapeutics Development
- An Overview of Pipeline Products for Lyme Disease
- Lyme Disease Therapeutics under Development by Companies
- Lyme Disease Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Lyme Disease Therapeutics - Products under Development by Companies
- Lyme Disease Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Lyme Disease Therapeutics Development
- Intercell AG
- Lyme Disease - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Lyme Borreliosis Vaccine - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Isac - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Ceftriaxone + Doxycycline - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
For more information visit http://www.researchandmarkets.com/research/aedc8e/lyme_disease_pip